Sign inJoin waitlistJoin the waitlist

Nathan Robison

Physician · Childrens Hospital Los Angeles

Credentials: · · · · · ·

History

Childrens Hospital Los Angeles
2019–Present

Keck Medicine of USC
2005–2006
Pediatrics
2002–2005
Keck Sch of Med of the Univ of Southern Calif
1998–2002

Research

Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database
Pediatric Blood & Cancer · 2014 · 235 citations
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group
Review · The Lancet Oncology · 2020 · 158 citations
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform…
Journal of Clinical Oncology · 2021 · 118 citations

Ashley Margol
12 papers
Girish Dhall
11 papers
JF
Jason Fangusaro
9 papers
MK
Mark Kieran
9 papers
Michael Fisher
9 papers
Roger Packer
8 papers
Stewart Goldman
7 papers
Jennifer Cotter
6 papers · 2 as a fellow
Mark Krieger
6 papers
Nicole Ullrich
6 papers
PM
Peter Manley
6 papers
Pratiti Bandopadhayay
6 papers

Clinical trials

Study of MEK162 for Children With Low-Grade Gliomas
Principal investigator · Completed · Phase 1, Phase 2
Children's Hospital Los Angeles
2016–2025
International Rare Brain Tumor Registry
Site PI · Recruiting
Children's National Research Institute
2023–2033
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2020–2030
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
Sub-investigator · Recruiting · Phase 2
University of Alabama at Birmingham
2025–2032